See every side of every news story
Published loading...Updated

Russell Investments Group Ltd. Buys 12,941 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Summary by defenseworld.net
Russell Investments Group Ltd. lifted its stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 86.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 27,966 shares of the biotechnology company’s stock after buying an additional 12,941 shares during the period. Russell Investments Group Ltd.’s holdings in BioCryst Pharmaceuticals were worth $210,000 at the end of the mo…

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

defenseworld.net broke the news in on Friday, April 25, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.